Company page
Trisalus Life Sciences, Inc.
Trisalus Life Sciences, Inc. is a public company traded under the ticker TLSI in the American market. The company has a market capitalization of approximately $250.6 million. Trisalus focuses on developing innovative therapies for patients with cancer and other serious diseases.
- Ticker
- TLSI:NASDAQ
- Asset type
- Stock
- Market cap
- $250.6M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD